These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32989074)

  • 21. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy.
    Nichols L; Pfeifer K; Mammen AL; Shahnoor N; Konersman CG
    J Gen Intern Med; 2015 Dec; 30(12):1879-83. PubMed ID: 25855481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
    Waters MJ; Limaye V
    Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and myositis: the role of anti-HMGCR antibodies.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
    Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying statin-associated autoimmune necrotizing myopathy.
    Albayda J; Christopher-Stine L
    Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins.
    Salar T; Jimenez M; Hameed M; Ocon A
    Cureus; 2023 Jun; 15(6):e40552. PubMed ID: 37465805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
    Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of Statin-Induced Necrotizing Myopathy: Contribution of Anti-HMGCR Antibodies.
    Fidalgo C; Mendes A; Cunha R; Rodrigues F
    Acta Med Port; 2022 Jul; 35(7-8):584-587. PubMed ID: 34592132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
    Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoimmune myopathy associated with statin use].
    Ljøstad U; Mygland Å
    Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1360-2. PubMed ID: 27637055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Statin-Associated Autoimmune Myopathy: Management and Treatment.
    Malone M; Lahmar A; Siddique A; Rozboril M; Kresak JL
    J Prim Care Community Health; 2023; 14():21501319221148635. PubMed ID: 36688423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
    Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.
    Torri F; Ali G; Chico L; Siciliano G; Ricci G
    Acta Myol; 2021 Jun; 40(2):105-108. PubMed ID: 34355128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies.
    Garabet R; Herr S; Griffin N; Reddy K
    Rheumatol Int; 2024 May; 44(5):955-959. PubMed ID: 38461445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limb girdle muscular disease caused by
    Yogev Y; Shorer Z; Koifman A; Wormser O; Drabkin M; Halperin D; Dolgin V; Proskorovski-Ohayon R; Hadar N; Davidov G; Nudelman H; Zarivach R; Shelef I; Perez Y; Birk OS
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2217831120. PubMed ID: 36745799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with reduced oral steroid dosage in an 81-year-old woman with statin-induced anti-HMGCR immune-mediated necrotizing myopathy.
    Kondo S; Kurihara M; Higashihara M; Hara M; Nishina Y; Iwakiri R; Murayama S; Saito Y; Iwata A
    Geriatr Gerontol Int; 2024 Jul; 24(7):739-742. PubMed ID: 38860537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin induced necrotizing autoimmune myopathy.
    Babu S; Li Y
    J Neurol Sci; 2015 Apr; 351(1-2):13-17. PubMed ID: 25765229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical presentation of anti-HMGCR myopathy.
    Karna R; Singh R; Marshall C; Johnston A
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34544705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins as a possible cause of inflammatory and necrotizing myopathies.
    Padala S; Thompson PD
    Atherosclerosis; 2012 May; 222(1):15-21. PubMed ID: 22154355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.